2011
DOI: 10.1111/j.1600-0854.2011.01177.x
|View full text |Cite
|
Sign up to set email alerts
|

Recombinant Heptameric Coatomer Complexes: Novel Tools to Study Isoform‐Specific Functions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
28
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
7
2

Relationship

5
4

Authors

Journals

citations
Cited by 25 publications
(28 citation statements)
references
References 41 publications
0
28
0
Order By: Relevance
“…Invitrogen Sf9 cells were tested by the manufacturer for contamination of bacteria, yeast, mycoplasma and virus and were characterized by isozyme and karyotype analysis. We used a baculoviral expression system essentially as described previously (Sahlmüller et al, 2011) with a ‘One-Strep-Tag’ at the C-terminus of α-COP. Recombinant S. cerevisiae myristoylated Arf1, and human nucleotide exchange factor ARNO, were purified from E. coli as described previously (Chardin et al, 1996; Randazzo et al, 1992).…”
Section: Methodsmentioning
confidence: 99%
“…Invitrogen Sf9 cells were tested by the manufacturer for contamination of bacteria, yeast, mycoplasma and virus and were characterized by isozyme and karyotype analysis. We used a baculoviral expression system essentially as described previously (Sahlmüller et al, 2011) with a ‘One-Strep-Tag’ at the C-terminus of α-COP. Recombinant S. cerevisiae myristoylated Arf1, and human nucleotide exchange factor ARNO, were purified from E. coli as described previously (Chardin et al, 1996; Randazzo et al, 1992).…”
Section: Methodsmentioning
confidence: 99%
“…Recombinant coatomer protein was expressed and purified, as described in Sahlmuller et al, (2011). In short, Sf9 insect cells were infected with baculovirus encoding for heptameric coatomer.…”
Section: Methodsmentioning
confidence: 99%
“…Recombinant coatomer (;1.3 mg/mL) (Sahlmuller et al 2011) or the respective buffer was co-injected with 1:10 diluted Alexa488-labeled secondary antibodies (Invitrogen) into stable HeLa cells using a FemtoJet microinjection device (Eppendorf) mounted on an Axiovert 35 microscope (Zeiss). Three to 6 h after microinjection, cells were transfected with a siRNA against COPB1 (Ambion, 24546) and induced for reporter protein expression 4 h posttransfection.…”
Section: Microinjection Of Recombinant Coatomermentioning
confidence: 99%